Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,600.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividends Calendar - Week Ahead

Tue, 07th Apr 2015 05:21

UK Dividends Calendar 
Tuesday, April 7 
Blackrock North American Income TrustDividend payment date 2015
BlackRock Throgmorton TrustDividend payment date 2014
DiageoDividend payment date 2015
Electronic Data ProcessingDividend payment date 2014
PZ cussonsDividend payment date 2015
RenishawDividend payment date 2015
RicardoDividend payment date 2015
Standard Life UK Smaller Companies TrustDividend payment date 2015
Alumasc GroupDividend payment date 2015
Dechra PharmaceuticalsDividend payment date 2015
Independent Investment TrustDividend payment date 2014
Eco Animal Health GroupDividend payment date 2015
Wednesday, April 8 
AvivaEx-Dividend Date 2014
Crest NicholsonDividend payment date 2014
Galliford TryDividend payment date 2015
Haynes PublishingDividend payment date 2015
HaysDividend payment date 2015
SafestoreDividend payment date 2015
Thursday, April 9 
Asian Total Return Investment Company Ex-Dividend Date 2014
Martin Currie Global Portfolio TrustEx-Dividend Date 2014
Oxford InstrumentsDividend payment date 2015
4imprintEx-Dividend Date 2014
Aberdeen UK Tracker TrustEx-Dividend Date 2014
BBA AviationEx-Dividend Date 2014
BerendsenEx-Dividend Date 2014
GreggsEx-Dividend Date 2014
IDOXEx-Dividend Date 2014
ChesnaraEx-Dividend Date 2014
EMISEx-Dividend Date 2014
GKNEx-dividend date 2014 final
Esure GroupEx-dividend date 2014 final
James Fisher & SonsEx-dividend date 2014 final
Henderson High Income TrustEx-Dividend Date 2014
IMIEx-Dividend Date 2014
International Personal FinanceEx-Dividend Date 2014
JPMorgan Mid Cap Investment TrustDividend payment date interim 2015
Manchester & London Investment TrustEx-dividend date 2015
RotorkEx-Dividend Date 2014
St IvesEx-dividend Date 2015
St James's PlaceEx-Dividend Date 2014
Standard Life UK Smaller Companies TrustEx-Dividend Date 2014
Taylor WimpeyEx-Dividend Date 2014
Ulra ElectronicsEx-Dividend Date 2014
John WoodEx-Dividend Date 2014
GlaxoSmithKlineEx-Dividend Date 2014
Rio TintoEx-Dividend Date 2014
XP PowerEx-Dividend Date 2014
VesuviusEx-Dividend Date 2014
JPMorgan Senior Secured Loan FundEx-dividend Date 2015
NextSpecial dividend payment date 
Manchester & London Investment TrustSpecial dividend payment date 
Friday, April 10 
Hargreaves LansdownDividend payment date interim 2015
Mid Wynd International Investment Trust Dividend payment date 2015
Go-AheadDividend payment date 2015
CarcloDividend payment date 2015
Ashmore GroupDividend payment date 2015
BlackRock Income Strategies TrustDividend payment date 2015
Domino Printing SciencesDividend payment date 2014
Dunelm GroupDividend payment date 2015
Land SecuritiesDividend payment date 2015
London Finance & Investment GroupDividend payment date 2015
RMDividend payment date 2014
S&UDividend payment date 2014
Scottish American Investment Company Dividend payment date 2014
JPMorgan European Investment Trust Dividend payment date 2015
Monday, April 13 
No Events Scheduled  
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.